GE Healthcare CEO on 3Q Earnings Beat, Impact of AI

Peter Arduini, CEO of GE Healthcare, described radiopharmaceuticals as a fast-growing field that is advancing treatment and care in cancer, cardiology imaging and neurology, including Alzheimer’s-related approaches. Because these products have short half-lives and can dissipate by the end of the day, he said control of manufacturing and the supply chain is especially important. He speaks with Romaine Bostick & Kristine Aquino on "The Close,." (Source: Bloomberg)